Clinical Trials Related to BioMarin Pharmaceutical

Related studies linked through entity extraction aliases.

Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet

Status: COMPLETED
Phase: PHASE3

A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels

Status: COMPLETED
Phase: PHASE3

Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)

Status: COMPLETED
Phase: N/A

Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria

Status: COMPLETED
Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels

Status: COMPLETED
Phase: PHASE3

Study of rhASB in Patients With Mucopolysaccharidosis VI

Status: COMPLETED
Phase: PHASE3

Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI

Status: COMPLETED
Phase: PHASE3

Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI

Status: COMPLETED
Phase: PHASE2

Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI

Status: COMPLETED
Phase: PHASE1